David Cheresh
Member of Advisory BoardDr. David Cheresh, Ph.D., serves as Member of Scientific Advisory Board of Angiocrine Bioscience, Inc. He is Scientific & clinical advisor of Lassogen, Inc. Dr. David Cheresh, Ph.D., is a Professor in the Departments of Immunology and Vascular Biology of The Scripps Research Institute. Dr. Cheresh serves as Chair for Research Department of Pathology, University of California, San Diego UCSD and as Professor, Department of Pathology, Moores UCSD Cancer Center. He is Expert in liposome/nanotechnology, angiogenesis, cell survival, integrins, signal transduction, tumor invasion and extracellular matrix. He co-founded TargeGen, Inc. in 2002. He also Co-founded Kinagen, Inc. His laboratory focuses on the role of adhesion receptors and growth factors in the angiogenesis of tumors. Dr. Cheresh was promoted to Assistant Professor in 1985 and to Professor in the Departments of Immunology and Vascular Biology in 1996. He served as Chairman and Member of the Scientific Advisory Board of TargeGen Inc. He serves as Associate Editor for several major scientific journals and is on the advisory Board of several others. He served as Member of Translational Scientific Advisory Board at IVERIC bio, Inc. (formerly known as Ophthotech Corporation). He has been a Member of Scientific Advisory Board at Kinagen, Inc. since May 2010 and serves as its Director. He serves as Member of Advisory Board of Imunon, Inc. (formerly known as Celsion Corporation) He has been a Member of the Pathobiochemistry Study Section of NIH and sits on the Scientific Advisory Board for the Keystone Symposia. In 1982, he joined to The Scripps Research Institute as a postdoctoral fellow in the Department of Immunology. He has published extensively in the areas of cancer and angiogenesis research. Dr. Cheresh is a Distinguished Professor and Vice Chairman of Pathology at the University of California, San Diego (UCSD) School of Medicine and the Associate Director for Translational Research at the Moores UCSD Cancer Center. Dr. Cheresh is a leading authority in identifying key pathways and mediators of pathologic angiogenesis in tumors and has led efforts to develop new collaborations and programs in clinical and basic science with an emphasis on translational medicine. Dr. Cheresh is the recipient of several awards including the 15th Hans Linder Memorial Lecture, from the Weizmann Institute of Science, in Rehobot, Israel, the XXIII Annual Myron Karon Memorial Lectureship, from the University of Southern California, the Robert Flynn Professorship Award from Tufts University School of Medicine and he was a recipient of the American Cancer Society Faculty Research Award and a Merit Award from the National Institutes of Health. Dr. Cheresh received his doctorate in Immunology from the University of Miami School of Medicine and completed a postdoctoral fellowship in the Department of Immunology at The Scripps Research Institute.
Positions
- Company NameImunon, Inc.Stock CodeIMNNPositionMember of Advisory BoardColleagues
- MHMichael H. TardugnoExecutive Chairman
- SRStacy R. LindborgPresident, CEO & Director
- DVDouglas V. FallerChief Medical Officer
- JBJoshua BlacherCFO, Principal Financial Officer & Principal Accounting Officer
- KLKristin LongobardiSenior Vice President of Strategic Operations
- FJFrederick J. FritzIndependent Director
- JEJames E. DentzerIndependent Director
